Sysmex (OTCMKTS:SSMXY) Announces Quarterly Earnings Results

Sysmex (OTCMKTS:SSMXY) posted its quarterly earnings results on Tuesday. The company reported $0.10 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.10, Zacks reports. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex updated its FY 2026 guidance to 0.415-0.415 EPS.

Sysmex Price Performance

OTCMKTS:SSMXY traded up $0.02 during trading hours on Tuesday, reaching $13.57. The company had a trading volume of 515 shares, compared to its average volume of 216,702. Sysmex has a one year low of $8.01 and a one year high of $13.57. The company has a quick ratio of 2.53, a current ratio of 3.40 and a debt-to-equity ratio of 0.23. The stock has a 50-day moving average of $12.01 and a two-hundred day moving average of $10.03. The firm has a market capitalization of $8.25 billion, a PE ratio of 32.30 and a beta of 1.20.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis.

The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.